BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30102806)

  • 1. Antiproliferative potential of miR-33a in laryngeal cancer Hep-2 cells via targeting PIM1.
    Karatas OF
    Head Neck; 2018 Nov; 40(11):2455-2461. PubMed ID: 30102806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis.
    Wu L; Xia L; Chen X; Ruan M; Li L; Xia R
    Leuk Res; 2021 Jul; 106():106565. PubMed ID: 33865032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proto-oncogene Pim-1 is a target of miR-33a.
    Thomas M; Lange-Grünweller K; Weirauch U; Gutsch D; Aigner A; Grünweller A; Hartmann RK
    Oncogene; 2012 Feb; 31(7):918-28. PubMed ID: 21743487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.
    Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B
    Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
    Shen N; Huang X; Li J
    Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.
    Deng D; Wang L; Chen Y; Li B; Xue L; Shao N; Wang Q; Xia X; Yang Y; Zhi F
    Cancer Sci; 2016 Jul; 107(7):899-907. PubMed ID: 27088547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.
    Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y
    Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1.
    Liu Y; Zhang J; Xing C; Wei S; Guo N; Wang Y
    Cancer Biomark; 2018; 23(2):269-277. PubMed ID: 30103304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.
    Chen X; Zhang L; Tang S
    Auris Nasus Larynx; 2019 Feb; 46(1):106-113. PubMed ID: 29843929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma.
    Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A
    Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer.
    Zhang Y; Hu H
    Tumour Biol; 2017 Jun; 39(6):1010428317699417. PubMed ID: 28631575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-379 inhibits laryngeal carcinoma cell proliferation and invasion through directly targeting TCF-4.
    Wei JL; Zhang L; Zhao ZM; Zhao YZ; Fu Q; Yang Y
    Kaohsiung J Med Sci; 2019 Dec; 35(12):731-738. PubMed ID: 31436384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of DGCR5 enhances the radiosensitivity of human laryngeal carcinoma cells via inducing miR-195.
    Tang T; Shan G; Zeng F
    J Cell Physiol; 2019 Aug; 234(8):12918-12925. PubMed ID: 30549038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma.
    Pan XP; Wang HX; Tong DM; Li Y; Huang LH; Wang C
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1254-1263. PubMed ID: 28387905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.
    Han SY; Han HB; Tian XY; Sun H; Xue D; Zhao C; Jiang ST; He XR; Zheng WX; Wang J; Pang LN; Li XH; Li PP
    Oncotarget; 2016 Jul; 7(27):42461-42473. PubMed ID: 27285759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Growth inhibitory effect of microRNA-519b-3p on larynx squamous Hep-2 cells].
    Shen Z; Zhan G; Deng H; Kang C; Guo J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 49(2):151-6. PubMed ID: 24742516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.
    Ma H; Lian R; Wu Z; Li X; Yu W; Shang Y; Guo X
    Tumour Biol; 2017 Oct; 39(10):1010428317706224. PubMed ID: 29019284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.
    Kuo PL; Liao SH; Hung JY; Huang MS; Hsu YL
    Biochim Biophys Acta; 2013 Jun; 1830(6):3756-66. PubMed ID: 23458685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miR-145 in human laryngeal squamous cell carcinoma.
    Karatas OF; Yuceturk B; Suer I; Yilmaz M; Cansiz H; Solak M; Ittmann M; Ozen M
    Head Neck; 2016 Feb; 38(2):260-6. PubMed ID: 26083661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.